COMPANY PROFILE

Dimension Inx

3D painting biomaterials design and manufacturing system that offers the versatility, manufacturability, and affordability necessary for widespread adoption of regenerative tissue-engineered medical…

Chicago, United StatesFounded 2017Biotech & Life Sciences

Valuation $50–100M Last recorded · 2023

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Dimension Inx

Dimension Inx operates in the regenerative medicine sector, focusing on creating biofunctional microenvironments that aid in the body's natural healing processes. The company designs and manufactures materials that emulate the body's microarchitecture, providing a blueprint for tissue regeneration. Their primary clients include healthcare providers, research institutions, and biotech companies. Dimension Inx leverages a materials-centric approach to address patient needs, ensuring superior biofunctionality within the body. The business model revolves around the development and commercialization of these advanced medical solutions, generating revenue through product sales and collaborations with medical and research entities.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Chicago, United States
Employees: 26
Open positions: None listed
Dealroom signal: 66.8/100
Industry: Health
Sub-industry: BioTechnology, Health Platform
Sector: Biotech & Life Sciences, Biotechnology, Biomaterials, Spinout, Biotech and Pharma, DT and LS, science-based
Technology: 3D Technology
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Feb 2023	$12M	$48M	KdT Ventures · Solas BioVentures · Portal Innovations · Rise of the Rest	↗
EARLY VC✓Equity / VC	Nov 2021	$2.3M	$9.2M	Undisclosed	—

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Dimension Inx website traffic

Latest recorded traffic for Dimension Inx is 620 monthly website visits, down 61.3% over the last three months. Dimension Inx's team declined 10.3% over the past year.

Latest monthly visits620 3-month web change-61.3% 1-year team growth-10.3%

Monthly website visitsJun 2020–Jun 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CECellbricksBiofabricated human tissue therapeutics for organ regeneration.	Berlin, Germany	Operational	29	$8.4M	$31M
ALAxCell LabsA new look at the most widespread biomaterial in the world	Sherbrooke, Canada	Operational
STSuzhou Leadsynbio TechnologyInnovative synthetic biology solutions for efficient R&D and manufacturing of advanced bioproducts	China	Operational
RBRocRock BiotechnologyDeveloper of genetic editing, biomaterials, and treatment for solid tumors platforms	Ningbo, China	Operational
EBEV BiotechMicrobial cell factory (MCF) strain development company	Groningen, Netherlands	Operational
ATAtelerixAlginate hydrogel for transporting cells at ambient temperatures	Newcastle upon Tyne, United Kingdom	Operational
KBKuros BiosciencesBiologic implants to promote bone healing in spinal and orthopaedic surgery	Zurich, Switzerland	Operational
COCollplantRegenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing	Ness Ziona, Israel	Operational